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Abstract
The world is facing a mental health crisis and one of the most vulnerable groups are
college-age young adults. The crisis has only been exacerbated by the Sars-CoV2 pandemic
(commonly referred to as COVID-19). One way scientists are attempting to deal with the
increasing prevalence of psychiatric disorders is through studying their genetics using genome
wide association studies (GWAS). Scientists have begun to uncover genetic variants associated
with the development and potential treatments for these disorders. This thesis followed a cohort
of diverse, college-aged young adults from West Chester University of Pennsylvania both before
and during the COVID-19 pandemic. The cohort had been previously genetically tested using
AncestryDNA and through self-reported surveys, both pre and mid-pandemic. Analysis of the
data revealed higher rates of psychiatric disorders in the college cohort compared to the general
population. Also, an increase in alcohol consumption was discovered during the pandemic. The
data highlights the need for special attention and proper resources to be given to this group due
to their increased risk of mental health issues.
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Chapter 1: Introduction
Introduction
When students enter college, they are faced with many challenges beyond academics.
College-aged students also deal with the transition from high school routines, work and
extracurricular responsibilities, separation from home, and/or additional family responsibilities.
Due to these additional stresses, many students experience the first onset of mental health and
substance use problems or challenges during college. College students are a very unique group
and should be studied more to gain a better understanding of what mental health and substance
abuse issues they face and how best to address the potential problems that could arise.
In this review, we will explore different psychiatric disorders, such as depression,
anxiety, alcohol use, cannabis use, and suicidality, as well as the best known clinical practices
for identification and quantification of these disorders. There will be a specific focus on collegeaged young adults and the effects of the COVID-19 pandemic on mental health.
Depression
Depression is a well-known, persistent, psychiatric disorder associated with reduced
quality of life and overall poor health (Judd et al., 2000; Moussavi et al., 2007; Zivin et al.,
2009). The overall prevalence of depression is increasing as seen in The Global Burden of
Disease study which found a 33.4% increase in depressive disorders since 1990 (Study, 2017).
Studies such as these indicate that depression and other depressive disorders are a continually
growing worldwide issue. Common depressive symptoms have been linked to other serious
physical issues including insomnia, hypertension, risk of heart attack, infection, immune
dysfunction, and overall mortality (Adams et al., 2008; Doom & Haeffel, 2013; Rovner et al.,
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1991). In addition to the clinical implications of the disease, there is also a serious economic cost
on both a personal and societal level (Greenberg et al., 2015).
One important topic when looking at depression is comorbidity with other diseases and
conditions. Depression is regularly associated with other physical and psychiatric issues such as
anxiety disorders, substance abuse, personality disorders, and chronic illness (Hasin et al., 2018;
Kang et al., 2015; Melartin et al., 2002; Rush, 2007). The combination of depression and an
additional comorbid or psychiatric condition has been found to increase symptom severity as
well as the economic burden of the disease (Blanco et al., 2012; Greenberg et al., 2015; IsHak et
al., 2014; Joffe et al., 1993). Comorbidities also affect the treatment of depression and have been
linked to reduced efficacy of common treatments (Aina & Susman, 2006; Fava et al., 2008;
Iosifescu et al., 2004). Clinicians have become aware that comorbidities should be treated in
conjuncture with depression if patients are to see any significant improvements (Brown et al.,
1997; Coplan et al., 2015; Koike et al., 2002; Nunes & Levin, 2004).
Looking at college-aged students, focusing on young adults specifically, depression has
been found to have negative impacts on overall health, immunity, well-being, and even academic
performance (Adams et al., 2008; Doom & Haeffel, 2013; Eisenberg et al., 2009; Gili et al.,
2013; Hasin et al., 2018). One study found common depressive symptoms have been linked to
poorer mental well-being specifically in undergraduate students (Keum et al., 2018). An analysis
of the Healthy Minds Study cohort from 2005 associated increase depression severity with a
significant decrease in grade point average and increase in risk of dropping out or withdrawing
from school (Eisenberg et al., 2009). Studies have also discovered evidence of college students
suffering from depression at higher rates than the general population (Beiter et al., 2015; Ibrahim
et al., 2013). Just as frightening was the discovery that overall prevalence of depression appears
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to be increasing amongst college students as well (Lipson et al., 2019; SAMHSA, 2019). One
study discovered a significant increase in prevalence between the years of 2005 and 2014
(Mojtabai et al., 2016). In addition, there appears to be a similar comorbidity trend with college
students as seen in the general population. There is a proven correlation between anxiety and
depression in young collegiate adults (Tanaka-Matsumi & Kameoka, 1986). As found with
general populations, comorbidities can prevent or counteract proper successful treatments in
college students (DeVido & Weiss, 2012; Ramsey et al., 2005). Depression and its associated
comorbidities put students at increased risk and have negative implications on both their overall
well-being and academic endeavors (Davis et al., 2005; Eisenberg et al., 2009; Greenberg et al.,
2015; Turner et al., 2013).
Anxiety
Another psychiatric disorder, commonly investigated in terms of mental health, is
anxiety. There are a wide variety of anxiety disorders including generalized anxiety disorder
(GAD), panic disorders, specific phobias, and social phobias (Goodwin, 2015). This spectrum of
anxiety can make it difficult to define, classify, and diagnose the disorder (Goodwin, 2015).
Studies suggest that around 6% of the general population suffers from anxiety (Goodwin et al.,
2020; Wittchen & Jacobi, 2005). While this number may seem small, anxiety disorder poses very
serious implications both personally and community wide. Anxiety and its symptoms have been
associated with greater risk for suicide attempts, mortality, hospitalization, and heart disease
(Ringbäck Weitoft & Rosén, 2005). It is well documented that there is a strong link between
anxiety and depression and that the two diseases are often comorbid (Goodwin, 2015; Hasin et
al., 2018; Hirschfeld, 2001; Melartin et al., 2002; Ryan et al., 2013).
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In the United States, the overall percentage of the adult population suffering from anxiety
has increased from 5.12% to 6.68% over ten years (Goodwin et al., 2020). This same study
found the most notable increase in anxiety was in the 18-25 age group, with a jump of 7.97% to
14.66% (Goodwin et al., 2020). Other studies support this trend and have concluded young
adults often report higher rates of anxiety and stress than the general population (Beiter et al.,
2015; Pedrelli et al., 2015). Like depression, anxiety appears to be disproportionately affecting
young adults and could have serious impacts on their well-being.
Substance Use
Substance use disorder must be analyzed when discussing psychiatric diseases, especially
when focusing on young adults. In the general population, alcohol use is one of the leading
causes of mortality and morbidly and the World Health Organization (WHO) ranks it in its top
five risk factors for disease burden (Coulton, 2011). The prevalence of hazardous alcohol use is
estimated to be around 23% on average (Coulton, 2011). In college students, prevalence of
alcohol consumption is estimated at about 65% (White & Hingson, 2013). This is a significantly
higher percentage than the general population and even more frightening when considering it has
been discovered large percentages of college students binge drink or drink in excess, commonly
defined as consuming five or more drinks in one sitting (White & Hingson, 2013). Some
consequences of college drinking include missing classes, lower grade point averages, physical
injury, sexual assault, overdosing, memory blackouts, alterations in normal brain function, and
death (White & Hingson, 2013). College students who report higher depression scores and
symptoms also often report increased levels of alcohol consumption (Doom & Haeffel, 2013;
Keum et al., 2018). A large study focusing on young adults concluded individuals with poor
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mental health and depression were often associated with drinking related harm (Weitzman,
2004).
Several studies have estimated average cannabis usage in college students is around 30%
(Kosviner et al., 1974; Mohler-Kuo et al., 2003), with a 10% rate of dependence in first year
college students (Caldeira et al., 2008). There has also been a significant increase in cannabis
usage in college students over the last three decades (Schulenberg et al., 2019). One major
consequence for college students with the increase in cannabis usage is significant decline in
grade point averages (Martinez et al., 2015). Similar to alcohol use, there is a significant
difference between the general student population habits and those students who are struggling
with other psychiatric disorders (Beck et al., 2009; Moitra et al., 2016). Studies have identified a
correlation between the severity of depression symptoms and differences in cannabis usage in
college students (Beck et al., 2009; Moitra et al., 2016). Also, college students with symptoms of
depression are more likely to use cannabis (Garlow et al., 2008; Hayatbakhsh et al., 2007;
Tanaka-Matsumi & Kameoka, 1986) and report more frequent usage than their peers
(Hayatbakhsh et al., 2007).
Suicidality
Suicide is a worldwide issue, and the WHO estimates it accounts for 1.4% of premature
deaths and the death of 800,000 individuals annually (Bachmann, 2018). This makes suicide a
leading cause of injury and death worldwide (Nock et al., 2008). In addition to the emotional and
mental burden caused by suicide, the Institute of Medicine estimates that the United States loses
around $11.8 billion per year from the value of lost productivity (Bachmann, 2018). These
statistics are not helped by the fact that suicide and suicidality are difficult to define and
understand.
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Mental health professionals have concluded that suicidality actually exists as a continuum
(Raue et al., 2014). There are different levels and types of suicidal ideation such as thoughts,
feelings, or intentions that then represent different levels of suicide risk (Raue et al., 2014).
Ideation can range from passive thoughts of death to thorough planning and intention and
eventually escalate to the next level, behavior, where these thoughts are put into practice through
self-injury (Raue et al., 2014). Due to the high prevalence of suicide, studies have broken down
data to focus on risk-factors. Age has been found to have a huge impact on suicide, with geriatric
adults and young adults having higher rates of suicide than the general adult population (Dutheil
et al., 2019; Raue et al., 2014). Other high-risk populations include those of low socioeconomic
status, healthcare professionals, and minority populations (Dutheil et al., 2019). Focusing now
specifically on college age students, in 2013, suicide accounted for more than 6 deaths per
100,000 students, making it the second leading cause of death (Turner et al., 2013). Also,
circling back to the impact psychiatric disorders, it has been documented that suicidal ideation
and self-harm are more common in college students with depressive symptoms than their peers
without (Garlow et al., 2008).
Psychiatric Tests
Many psychiatric disorders have been studied extensively in literature, and even more
studies have been done recently due to the onset of the COVID-19 pandemic. Each disorder and
substance use described above; depression, anxiety, alcohol use, cannabis use, and suicidality;
has their own unique way of being classified and diagnosed by scientists.
When diagnosing depression, the Patient Health Questionnaire-9 (PHQ-9) is commonly
used. The PHQ-9 is a 9 question, self-report survey based on the DSM-IV criteria for depression
designed specifically to assess presence and severity of depressive symptoms occurring during
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the two weeks prior (Kroenke et al., 2001). Each question is asked on a scale of zero to three (0 =
not at all, 1 = several days, 2 = more than half the days, and 3 = nearly every day) for final scores
that result between 0 and 27 (Kroenke et al., 2001). Scores are often reported; 0-4 as minimal
depression, 5-9 as mild depression, 10-14 as moderate depression, 15-19 as moderately severe
depression, and 20 or greater as severe depression (Kroenke et al., 2001). This survey and
scoring method have been validated in the general population and college students, working
equally well regardless of sex, race, or ethnicity (Keum et al., 2018; Kroenke et al., 2001).
For anxiety, often the Generalized Anxiety Disorder-7 (GAD-7) is utilized. The GAD-7
is a well validated, 7 question, self-reported survey focusing on anxiety symptoms which have
occurred in the past two weeks (Spitzer et al., 2006). Similar to the PHQ-9 survey, the GAD-7
survey asks questions on a scale from zero to three (0 = not at all, 1 = several days, 2 = more
than half the days, and 3 = nearly every day) for final scores ranging between 0 and 21 and
reported as; 0-4 minimal anxiety, 5-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe
anxiety (Spitzer et al., 2006). Among collegiate students, this survey has been found to be a
reliable tool for detecting generalized anxiety symptoms (Bártolo et al., 2017).
Alcohol use disorder is evaluated using the Alcohol Use Disorders Identification Test
(AUDIT) is often chosen. AUDIT is a 10 question self-reported survey, designed to assess both
alcohol consumption, AUDIT-C, and problematic drinking, AUDIT-P (Lundin et al., 2015).
AUDIT scores have been shown to directly correlate with DSM-IV alcohol use disorder, alcohol
dependence, and alcohol risk drinking, as well as DSM-V criteria (Hagman, 2016; Lundin et al.,
2015). AUDIT-C is a 3 questions preliminary survey, asking participants only about their alcohol
consumption (Lundin et al., 2015). In certain studies, the AUDIT-C can be given simply as a
stand-alone survey (Bradley et al., 2007). The AUDIT-P are the remaining 7 questions of the full
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AUDIT survey and asks respondents to report on problems related to alcohol use (SanchezRoige et al., 2019). When AUDIT-C and AUDIT-P were separated, it was possible to discover
that they have different underlying genetics (Kranzler et al., 2019). Multiple studies on college
students have shown AUDIT to be an effective and accurate assessment of alcohol use
(Clements, 1999; Demartini & Carey, 2012; Hurlbut & Sher, 1992). In the general population,
there is evidence that PHQ-9 scores or depression symptom severity may be related to AUDIT
scores and alcohol use (Dum et al., 2008; Hepner et al., 2009).
Cannabis use is measured in a similar way as alcohol by using the Cannabis Abuse
Screening Test (CAST). CAST is a DSM-IV criteria validated 6 question self-reported survey of
cannabis usage over the previous year (Legleye et al., 2013). Scores of the six questions can
range from 0 to 24, with scores of 8 or greater being classified as severe cannabis use or
dependence (Legleye et al., 2013). CAST has been proven to be an effective assessment in
college students and college age young adults (Fernandez-Artamendi et al., 2012; Gyepesi et al.,
2014; Legleye et al., 2013; Serra et al., 2019).
Because suicidality is difficult to define, it is also often difficult to assess in studies. One
tool used specifically for pediatric patients is referred to as the Ask Suicide-Screening Questions
(ASQ) instrument. The ASQ is a validated 4-item self-report to detect suicidal thoughts and
behaviors in pediatric patients (Horowitz et al., 2020). Pediatric patients according to this
screening, are defined as 10 to 21 years of age, indicating this tool has overlap with the college
age young adult category (Horowitz et al., 2020). Scientists can also craft their own questions for
analysis based on the recommendations for how to assess suicide risk from professionals in the
field. One such example is the recommendations laid out in The American Psychiatric
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Association Practice Guidelines for the Psychiatric Evaluation of Adults (Silverman et al.,
2015).
COVID-19
In March 2020, the United States found itself in the grips of the SARS-CoV-2 global
pandemic, often more commonly referred to as COVID-19. This pandemic was instantly
classified as a healthcare crisis, as hospitals and clinics found themselves overwhelmed by the
sheer volume of cases. With lockdown and isolation, mental health professionals became very
aware that a mental health crisis could occur alongside the pandemic. COVID-19 has had an
enormous impact on psychiatric disorders and suicidality, particularly in college students and
young adults.
In the general adult population, the COVID-19 pandemic has been found to be positively
corelated with increases in depression and anxiety symptoms (Gloster et al., 2020; Jia et al.,
2021; Vahratian et al., 2021). Studies of trends suggest that there were associations between the
number COVID-19 cases / waves of the pandemic and subsequent increases and peaks in
psychiatric symptoms (Jia et al., 2021; Vahratian et al., 2021). The largest peak of reports of
increased depression and anxiety symptoms occurred between December 2020 and January 2021
(Jia et al., 2021; Vahratian et al., 2021). Since then, there has been a steady decrease in reported
symptom severity; however, it has been noted that despite this decrease, the average prevalence
of depression and anxiety are still higher in the general population than was reported prepandemic in 2019 (Jia et al., 2021; Vahratian et al., 2021). It has also been discovered there have
been increases in prevalence of other mental health disorders since the onset of the pandemic
including general health anxiety, stress reactions, panic attacks, irrational anger, posttraumatic
stress symptoms, insomnia, sleep disorders, and suicidal behavior (Banerjee et al., 2021; Hossain
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et al., 2020). High risk populations have been identified as individuals with pre-existing mental
health disorders, young adults, elderly adults, healthcare workers, and homeless and migrant
populations (Banerjee et al., 2021; Jia et al., 2021; Minihan et al., 2020; Vahratian et al., 2021).
There has been a call from professionals in the field for an increase in research, access to mental
health resources, and education for the general population and specifically the populations most
at risk (Banerjee et al., 2021; Jia et al., 2021; Minihan et al., 2020; Vahratian et al., 2021).
Professionals have identified the COVID-19 mental health crisis and have begun laying out
strategies for how best to move forward.
Due to their identification as a high-risk population, young adults and college students
have become of particular interest to mental health experts. Population wide studies have
discovered that the group with the largest increases in depression and anxiety symptoms, a jump
of 8%, are in fact those 18 to 29 years of age (Jia et al., 2021; Vahratian et al., 2021). There have
also been studies specifically focused on college students which have discovered increased
anxiety and other psychotic experiences due to the COVID-19 pandemic (Oh et al., 2021). In a
survey of US college students during the pandemic it was reported 48% were suffering from
moderate to severe depression, 38% were suffering from moderate to severe anxiety, and 18%
had reported experiencing suicidal thoughts (Wang et al., 2020). Just as scary as those high
percentages is that only 43% of those students indicated they felt adequately equipped to cope
with the current situation (Wang et al., 2020). One study of first year college students found a
7% increase in prevalence of moderate to severe anxiety from pre-pandemic to mid-pandemic as
well as a 10% increase in depression prevalence (Fruehwirth et al., 2021). Another study of first
year college students discovered students were significantly suffering with issues of
externalizing problems and attention as well as decreased reported overall mood and wellness

11
since the onset of the COVID-19 pandemic (Copeland et al., 2021). Some of the largest causes
for these trends have been identified as students having to relocate, general difficulties with
distance and online learning, and feelings of social isolation (Conrad et al., 2021; Fruehwirth et
al., 2021) There has been evidence that increased university support and wellness programs have
served to benefit students who are suffering from these increases in psychiatric symptoms and
issues (Copeland et al., 2021).
There is less literature specifically examining the effects of the pandemic on suicidality
and substance use in college students. However, one study specifically examining college
students with COVID-19 diagnoses, symptoms, and hospitalizations discovered suicidal ideation
was reported by 13%, suicidal planning by 5%, and suicide attempts by 1% (DeVylder et al.,
2021). Not only that, but it was discovered prevalence of these suicidal outcomes was greatly
increased in students with a COVID-19 diagnosis and those with increased symptom severity
(DeVylder et al., 2021). Another devastating finding was, of students hospitalized and reporting
suicidal ideation, 53% of those who were hospitalized for COVID made a suicide attempt
(DeVylder et al., 2021). With regards to substance use, a study examining alcohol use habits in
college students after the onset of the pandemic discovered that college students who moved
home actually decreased their frequency and amount of alcohol consumption (White et al.,
2020). However, students who reported remaining with peers were found to decrease their
average amount of alcohol but increase their frequency of days drinking per week (White et al.,
2020). Little research has been done on exploring how the cannabis habits of college students has
been altered.
There have been studies that seek to measure the psychological impact COVID-19 has
had on individuals. A common tool being utilized is the Perceived Stress Scale (PSS). Originally
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published in 1983, the Perceived Stress Scale is a frequently utilized self-reporting tool designed
to help understand how different situations, in this case COVID-19, affect participants feelings
and perceived stress (Cohen et al., 1983). An advantage of utilizing this scale is the considerable
volume of literature available for comparison of results. These questions are now being promoted
to collect COVID-19 related phenotyping data by the National Institute of Health (NIH) National
Institute of Environmental Health Sciences (COVID-19 OBSSR research tools Database ID
#22198).
Genetic Data
The field of genetics is complex, advanced, and not commonly understood by the public.
The study of genetics starts with genetic material, in this case DNA, and focuses inward on the
building blocks knows as nucleotides. Single nucleotide polymorphisms (SNPs) are variations at
just one nucleotide and are utilized by scientists to compare individuals and the genetic base of
their expressed phenotypes (Chanock, 2001; Corfield et al., 2010). Databases exist to record the
human genome and assess this variation to determine genotype and phenotype associations
(Chanock, 2001). These databases and the advancements in genotyping have led to a revolution
in terms of biology, evolution, and medicine (Chanock, 2001).
One term that is common with regards to genetics, is ancestry. Companies such as
AncerstryDNA, 23andMe, FamilyTreeDNA, and so many others have brought genetics into the
spotlight by using genomic data to report the ancestral history of individuals. What individuals
perhaps do not realize, is the number of studies and discoveries that have been made using their
genetic data beyond ancestry. Scientists have been using this massive amount of genetic data to
research the human genome on scales that were never possible in the past. Focusing on
AncestryDNA, this service uses microarray-based autosomal DNA testing on the saliva sample
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provided by the individual (AncestryDNA, 2022). This testing survey’s the entire genome at
around 700,000 different locations with 98% guaranteed accuracy according to the company’s
website (AncestryDNA, 2022). AncestryDNA promises its customers genetic ethnicity
predictions, DNA matching with family, and tools to help understand their DNA (AncestryDNA,
2022). Geneticists have found additional uses for this genetic data and have made innovative
discoveries thanks to the AncestryDNA public databank. Some have used genetic and ancestral
data to construct historic population structures and models (Han et al., 2017). Other studies have
utilized Ancestry data to identify genetic markers and loci associated with lifespan as well as
study the heritability of lifespan (Ruby et al., 2018; Wright et al., 2019). Other scientists have
used this data to examine risk of human diseases such as atrial fibrillation and even COVID-19
(Hateley et al., 2021; Upadhyai et al., 2021).
Scientists are discovering the genetic basis of common human diseases using
advancements in genotyping technology. More complex diseases and their genetic link remain a
mystery, including many psychiatric disorders. Psychiatric diseases are believed to be some of
the most frequent in humans with estimates of lifetime prevalence as high as 40% (van Belzen &
Heutink, 2006). Due to differences in diagnosis techniques, variance in clinical manifestations,
and sometimes incomplete understanding of the underlying biological mechanisms of these
diseases, it has been difficult to define definitive genetic links (Rao et al., 2021; van Belzen &
Heutink, 2006). However, scientists are continuing to study these diseases in order to discover
the genotype-phenotype linkages. One study of anorexia nervosa discovered two genetic tags as
well as a gene thought to be associated with the disorder (Baker et al., 2017). Another study
focusing on older adults reported both phenotypic markers and genetic risk factors were
transdiagnostic for their cohort (Gard et al., 2021). Studies have also been completed analyzing
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genetic links for ADHD, suicidal behavior, depression, and schizophrenia (Klein et al., 2019; Liu
et al., 2006; Rao et al., 2021; van Belzen & Heutink, 2006). One recent study by Rao et al.
examined 18 different psychiatric disorders and their biological mechanisms to better
differentiate between their identified genetic linkages (Rao et al., 2021). They discovered that
with more thorough understandings of these diseases from a biological standpoint, it is possible
to better identify and organize their genetic markers (Rao et al., 2021). An analysis of genetic
linkage studies performed by van Belzen & Heutink, suggested for this field to continue
progressing it is essential for there to be careful and details study design as well as the utilization
of systematic and efficient genotyping techniques (van Belzen & Heutink, 2006).
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Chapter 2: Materials and Methods
Introduction
To better understand the complex relationship between genetics and psychiatric
disorders, individuals who had previously been genotyped using AncestryDNA by Drs. Anita
Foeman and Bessie Lawton, from the Department of Communication and Media at West Chester
University (WCU) were surveyed. This study population was chosen for survey due to their
college young adult age and diverse background, both of which are understudied populations
genetically. A majority of the original cohort were members of the West Chester University
Honors College who were provided genetic tests through the HON 100 course. This survey
sought to document the phenotypes of different psychiatric disorders including depression,
anxiety, alcohol use, cannabis use, and suicidality. This initial round was conducted between
August 2019 and February 2020 and a total of 194 individuals completed the survey. To
establish a baseline and understand the prevalence of the psychiatric disorders in the study
population, this survey data was statistically analyzed, and the distributions and correlates of the
disorders were reported.
The serendipitous finalization of the initial surveys in February 2020, provided a cohort
of college age young adults who had self-reported different psychiatric tests immediately before
the outbreak of the global COVID-19 pandemic. In continuation of the initial study (referred to
as pre-COVID), a follow up survey (referred to as mid-COVID) was sent to all study participants
to examine the effects of COVID-19. 88 individuals completed the follow up survey in its
entirety. Changes in scores and prevalence of disorders were examined, to gauge the impact of
the pandemic on the mental health of college age young adults.

16
In the near future, Dr. Richard Crist and Dr. Benjamin Reiner, from the Center for Neurobiology
and Behavior at the Perelman School of Medicine at the University of Pennsylvania (Penn),
intend to use this combined genotypic and phenotypic data to analyze potential genetic variants
linked to these different psychiatric disorders.
Pre-COVID Survey
Initial Cohort Selection
Participants were 194 young adult undergraduate students (age range 18-30) who had previously
participated in an undergraduate genotyping study at WCU. All recruitment and study
procedures were approved by the WCU and University of Pennsylvania Institutional Review
Boards. All potential participants from the previously study, for which contact information was
available, were contacted by email between August 2019 and February 2020 and asked to
complete an online informed consent and phenotyping assessments utilizing the REDCap
electronic data capture tools (Harris et al., 2019; Harris et al., 2009) for modest renumeration in
the form of a ten dollar Amazon gift card. All reported demographic data, including age, sex,
race, and ethnicity, are based on individual self-report captured during online phenotyping. Of
the 194 individuals, 15 individuals self-reported as multi-racial, by selecting more than one race,
and were excluded from all correlation analyses, due to the difficult in controlling for multiracial status in statistical calculations.
Phenotyping Assessments
After digitally signing the online consent documents, participants were directed to complete a
demographics questionnaire, including age, sex, race, ethnicity, height, and weight. After
completing the demographics, participants were presented with a series of phenotyping surveys,
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detailed below, which were selected to assess psychiatric and addiction phenotypes amongst
participants.
Depression
Participants were phenotyped for depression using the PHQ-9, a brief self-report of depression
severity over the previous two weeks, which was designed to score the DSM-IV criteria for
depression on a scale of zero to three (Kroenke et al., 2001). Questions were scored with a range
of 0-27, with higher scores indicating a larger amount of depressive symptoms, and categories
for depressive severity were determined as previously described (Kroenke et al., 2001).
Anxiety
The anxiety levels of participants were determined using the (GAD-7) (Spitzer et al., 2006). The
GAD-7 is a validated measure of anxiety symptoms (Spitzer et al., 2006). Questions were scored
as previously described, for a score range of 0-21, with higher scores being indicative of
increased DSM-IV anxiety symptoms, and categories for anxiety severity were determined as
previously described (Spitzer et al., 2006).
Alcohol
Alcohol usage among participants was evaluated using the AUDIT, a brief questionnaire
designed to assess alcohol consumption (AUDIT-C; 3 questions) and problematic alcohol
drinking (AUDIT-P; 7 questions) (Lundin et al., 2015). AUDIT scores are correlated with DSMIV-alcohol use disorder, -alcohol dependence, and -alcohol risk drinking (Lundin et al., 2015).
Participants were initially presented with the questions for the AUDIT-C, and individuals scoring
≥4 were also asked to complete the AUDIT-P. All questions were scored as previously
described, with total scores ranging from 0-40 (Lundin et al., 2015).
Cannabis
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Cannabis usage among participants was evaluated using the CAST, a six question self-report
designed to assess cannabis use within the last year (Legleye et al., 2013). Total scores range
from 0-24 and scores have been validated using DSM-IV criteria for cannabis dependence
(Legleye et al., 2013). Participants were initial presented with a single question asking, “Have
you ever used cannabis?”. Participants who answered in the affirmative were then asked, “Have
you used cannabis within the past 12 months?”. Individuals who answered both prior usage
questions in the affirmative were presented with the six question CAST. Individuals who answer
in the negative to one or both introductory questions were assumed to have a CAST score of
zero. A total CAST score ≥8 was used as a cutoff for severe cannabis use disorder and
dependence, a score that was previously validated against DSM-IV criteria (Legleye et al.,
2013).
Suicidality
Suicidality amongst participants was evaluated with three questions, similar to those utilized in
the online mental health questionnaire of UK Biobank (Davis et al., 2020)*, to assess lifetime
suicide related behaviors amongst participants. Participants were asked to select “Yes” or “No”
for each question. To assess lifetime suicidal ideation (Suicide-Ideation), participants were
asked, “Have you ever thought about committing suicide?”. To assess suicide planning (SuicidePlan) and suicide attempts (Suicide-Attempt) amongst participants, participants were asked,
“Have you ever made a plan to commit suicide?” and “Have you ever attempted suicide?”,
respectively.
* Since the conclusion of the initial round of surveys, this study has been retracted due to a
statistical program error during data analysis (Davis et al., 2020). Because the issue did not lie
with the questions and format of the survey, the authors are still using the data as a valid source.
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However, during reassessment, other guidelines were used to model the suicidality questions
(Horowitz et al., 2020; Silverman et al., 2015).
Statistical Analysis
Data collected in REDCap was downloaded, deidentified, and scored as described above. Data
were analyzed using SPSS v24.0 and are presented as mean ± standard deviation. Associations
between phenotypes were examined using partial correlation or point-biserial correlation, as
appropriate, controlling for the effects of age, sex, race, and ethnicity. All statistical tests were
two-sided, and significance level was set a p ≤ 0.05.
Mid-COVID Reassessment Survey
Participant Selection
Participants were young adult undergraduate students (age range 19-30) from the original cohort
who had previously participated in a genotyping and epidemiological study at West Chester
University. All recruitment and study procedures for this follow-up survey were approved by the
WCU and University of Pennsylvania Institutional Review Boards. All potential participants
from the original cohort of 194 individuals, were contacted via email between April 2021 and
August 2021 and asked to complete a follow-up online informed consent, phenotyping
assessment, and perceived COVID impact questionnaire utilizing the REDCap electronic data
capture tools (Harris et al., 2019; Harris et al., 2009). Modest renumeration of a ten dollar
Amazon gift card was offered to participants who completed the survey. All demographic data,
such as age, sex, race, and ethnicity, are based on individual self-reports during online
phenotyping. Of the 194 initial individuals, 88 met the study requirements and completed the
survey in its entirety.
Phenotyping Assessments
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After electronically signing the online consent documents, participants completed a
demographics questionnaire including age, sex, race, ethnicity, height, and weight. Participants
were then presented with a series of phenotyping survey which assessed psychiatric, addiction,
and COVID impact phenotypes amongst participants. The demographic, AUDIT, CAST, PHQ-9,
and GAD-7 surveys remained the same as the initial survey. In the self-harm survey, additional
questions were included to assess specifically the impact of COVID-19 on participants suicidal
thoughts, plans, and attempts. Additional questionnaires, explained below, were included at the
end of the survey to assess COVID-19 impact and perceived stress of the participants.
COVID Impact Assessment
Individuals participating in the COVID-19 related portion of the study were asked to complete a
30-37 question, depending on answers, survey designed to examine the impact of the COVID-19
crisis on their psychological stress and related lifestyle and academic changes. This questionnaire
was based on a design by a research team at Stanford and the Perceived Stress Scale (Cohen et
al., 1983).
Perceived Stress Scale (PSS)
Perceived stress amongst participants was analyzed using the PSS 10 question survey. The
National Institute of Health (NIH) is promoting these questions to collect COVID-19 related
phenotyping data, COVID-19 OBSSR research tools Database ID #22198.
Statistical Analysis
Once again, the data collected using REDCap was downloaded, deidentified, and scored
according to the previously discussed descriptions. Data analysis was completed using SPSS
v24.0 and presented as the mean ± standard deviation. All statistical tests are two-sided with a
significance level of p ≤ 0.05.
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Chapter 3: Results
Pre-COVID Results
Participant Demographics
A total of 194 individuals completed this study, and their demographics, including age, gender,
race, and ethnicity, are summarized in Table 1.
Depression
The mean PHQ-9 score of participants was 6.65 ± 5.77, suggesting that, on average,
participants were characterized by mild depressive symptoms. Examination of the distribution of
total PHQ-9 scores (Table 2) indicates that ~57% of participants have a total PHQ-9 score ≥5,
indicating at least mild depression symptom severity. Furthermore, ~26% of participants have a
total PHQ-9 score ≥10, indicative of moderate or worse depression severity, and ~12% of
participants have a total PHQ-9 score ≥15, indicative of moderate severe or severe depression.
Taken together, these results indicate that depressive symptoms commonly occurred amongst our
cohort of collegiate young adults and that a substantial portion of our study participants had
considerable depressive severity.
Anxiety and correlation with depression
Participants had a mean GAD-7 score of 6.69 ± 5.50, suggestive of overall mild anxiety
symptoms among participants. The distribution of total GAD-7 scores (Table 3) indicates that
greater than half of participants, ~57%, have at least mild anxiety severity and ~29% of
participants have moderate or severe anxiety severity. Data analysis demonstrated a positive
correlation between PHQ-9 and GAD-7 total scores (r(173) = .738, p < 0.001; Table 4). These
data demonstrate that anxiety is both common and highly correlated with depression in our
collegiate cohort.
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Alcohol use and correlations with depression and anxiety
Alcohol usage amongst participants was common, with 32.0% reporting consuming
alcohol monthly or less, 27.3% two to four times a month, 15.0% two to three times a week, and
1.5% four or more times a week. The number of alcoholic drinks consumed per drinking day
trended toward low or moderate consumption, with 55.7% of participants reporting the
consumption of one to two drinks and 31.0% reporting the consumption of three or four drinks
per drinking day. Conversely, this indicates that ~13% of participants consumed five or more
drinks per drinking day. Participants had a mean total AUDIT score of 3.86 ± 4.08, with 17.5%
of participants having a total AUDIT score ≥8, indicative of harmful or hazardous drinking.
Total AUDIT scores suggested alcohol dependence, defined as a total AUDIT score ≥15 in
males and ≥13 in females, in 4.8% of male participants and 3.9% female participants. Total
AUDIT score was positively correlated with both PHQ-9 (r(173) = .183, p < 0.05) and GAD-7
(r(173) = .149, p = 0.050) total scores (Table 4). Intriguingly, these statistical interactions were
not driven by correlation of PHQ-9 and GAD-7 to alcohol consumption (AUDIT-C vs. PHQ-9,
r(173) = .107, p > 0.05; AUDIT-C vs. GAD-7, r(173) = .027, p > 0.05; Table 4), but alcohol
problems (AUDIT-P vs. PHQ-9, r(173) = .228, p < 0.01; AUDIT-P vs. GAD-7, r(173) = .255, p
< 0.01; Table 4). Taken together, our results suggest that the common, low to moderate alcohol
consumption by participants is not associated with increases in depression or anxiety severity.
However, participants exhibiting problematic drinking, as demonstrated by increased AUDIT-P
score, have significantly increased depression and anxiety severity.
Cannabis use and correlations with depression and anxiety
Participants reported a 43.3% lifetime history of cannabis use and 33.5% history of
cannabis use in the previous 12 months. Data analysis revealed that both having a positive
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history for lifetime cannabis use (r(173) = .158, p < 0.05; Table 4) and cannabis use during the
past 12 months (r(173) = .199, p < 0.01; Table 4) were positively correlated with total PHQ-9
score. However, neither lifetime cannabis use (r(173) = .104, p > 0.05; Table 4) or cannabis use
in the previous 12 months (r(173) = .113, p > 0.05; Table 4) was correlated with participant’s
total GAD-7 scores. Interestingly, despite known correlations of depression and anxiety, these
results suggest that lifetime and 12-month history of cannabis usage in our cohort of young adult
collegiate students is only associated with depression severity. The mean total CAST score of all
participants was 3.16 ± 5.05. Participants who reported using cannabis in the previous 12 months
had a mean total CAST score of 9.45 ± 4.10 and 52.3% had total CAST score ≥8, indicative of
severe cannabis use disorder and cannabis dependence (Legleye et al., 2013). The total CAST
score of all participants was positively correlated with both PHQ-9 total score (r(173) = .281, p <
0.001; Table 4) and GAD-7 total score (r(173) = .167, p < 0.05; Table 4). Taken together, these
results suggest that approximately half of participants who have utilized cannabis in the previous
12 months have CAST scores indicative of a clinical diagnoses of severe cannabis use disorder
and cannabis dependence with comorbid increases in depression and anxiety symptom severity.
Suicidality and correlations with depression and anxiety
Suicidality among participants was evaluated with three questions, addressing
participant’s lifetime history of suicide ideation, suicide planning, and suicide attempt.
Participants reported a 37.1% rate of lifetime suicidal ideation, a 14.9% rate of lifetime suicide
planning, and an 8.8% rate of lifetime suicide attempt. Positive lifetime history of both suicide
ideation and suicide planning were positively correlated with both PHQ-9 total score (Ideation
vs. PHQ-9, r(173) = .430, p < 0.001; Planning vs. PHQ-9, r(173) = .385, p < 0.001; Table 4) and
GAD-7 total score (Ideation vs. GAD-7, r(173) = .310, p < 0.001; Planning vs GAD-7, r(173) =

25
.245, p < 0.01; Table 4). Lifetime history of suicide attempt was positive correlated with PHQ-9
total score (r(173) = .267, p < 0.001; Table 4), but was not correlated to GAD-7 total score
(r(173) = .122, p > 0.05; Table 4). However, positive correlation between lifetime history of
suicide attempt and GAD-7 total score did trend toward significance (0.05 < p < 0.1).
Mid-COVID Results
Participant Demographics
A total of 88 individuals completed the survey in its entirety. The demographic
breakdown by age, gender, race, and ethnicity can be found in Table 5.
Depression
The mean PHQ-9 score was 6.33 ± 5.56, meaning the average participant would be
classified with mild depression severity. Examining the distribution of scores in Table 6, ~51%
of participants had scores greater than 5, indicating at least mild depression severity. Further
evaluation of the distribution finds 25% reporting mild depression, ~16% of participants
reporting moderate depression, ~8% reporting moderate-severe depression, and 2.3% of
participants reporting symptoms of severe depression. When comparing the average of the preCOVID PHQ-9 survey to the mid-COVID-19 PHQ-9 survey, there was a slight increase in
average score from 6.23 ± 5.97, however this increase was found not to be statistically
significant (t(87), p = 0.873; Table 7).
Anxiety
Participants had a mean GAD-7 score of 6.77 ± 5.73, indicating again the average
respondent was suffering from mild anxiety symptoms. According to the data distribution, 52.3%
of respondents reported at least mild anxiety, with 10.2% reporting moderate, and 15.9%
reporting severe (Table 8). When comparing the pre-COVID values to the mid-COVID values,
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again there is a slight increase from 6.57 ± 5.78, however this difference was also found not to be
significant (t(87), p = 0.644; Table 9).
Alcohol Use
The mean scores for the AUDIT total, AUDIT-C, and AUDIT-P were 4.51 ± 3.77, 3.25 ±
2.10, and 1.26 ± 2.40 respectively (Table 10). Alcohol consumption was common among
participants with 23.9% reporting alcohol consumption monthly or less, ~40% reporting
frequency of consumption at two to four times a month, 25% reporting two to three times a
week, and 1.1% reporting four or more times a week (Table 11). Generally, the number of drinks
per typical day of drinking was lower, with 51.1% reporting only 1 or 2 drinks, 35.2% reporting
3 or 4, and 13.6% reporting 5 or 6 drinks (Table 12). Approximately 16% of individuals reported
AUDIT total scores of ≥8, indicating harmful or hazardous drinking (Table 10). Only 2.27% of
females reported scores indicative of alcohol dependence (AUDIT score ≥13) and 0 males were
recorded as having alcohol dependence (AUDIT scores ≥15)(Table 10). When comparing preCOVID AUDIT responses to the mid-COVID-19 AUDIT responses in Table 13, there are a few
differences. The initial AUDIT total of 3.53 ± 3.65 was lower, but statistically not significant
(t(87), p = 0.0822), as was the initial AUDIT-P of 1.02 ± 1.85 (t(87), p = 0.4607). However,
when comparing the alcohol consumption AUDIT-C mean of 2.51 ± 2.29, a statistically
significant difference was discovered (t(87), p = 0.0271). This suggests COVID-19 may be
associated with increases in drinking consumption in the participants. An additional test was run
to assess the effect of legal drinking age (under or above 21 years old) on the AUDIT scores
(Table 14). Significance was found in the AUDIT-T and AUDIT-P scores, but not the AUDIT-C
(Table 14).
Cannabis Use

27
Participants reported 48.9% use of lifetime cannabis use and 38.6% cannabis use in the
last 12 months (Table 15). 21.6% of participants reporting cannabis use in the last 12 months
reported CAST scores ≥8, indicating severe cannabis use disorder and cannabis dependence
(Table 15). The average CAST score of all participants lifetime use was 3.70 ± 5.30, while the
average CAST score of those who reported smoking in the last 12 months was 9.59 ± 4.04
(Table 15). When compared to the pre-COVID CAST scores in Table 16, all mid-COVID scores
and proportions were higher, and trended toward significance (t(87), p = 0.064; Table 16).
Average total CAST scores went from 2.91 ± 4.89 initially to 3.70 ± 5.30 in COVID-19 reports.
Proportion of lifetime use and 12 month use both increased from 39.8% to 48.9% and 30.7% to
38.6% respectively.
Suicide
Suicide was analyzed using three questions to assess suicidal thought, planning, and
attempt and the distribution can be seen in Table 17. A large proportion, 43.2%, of participants
reported experiencing suicidal thoughts. Additionally, 15.9% of participants reported having a
suicide plan and 9.1% reported a suicide attempt. When analyzing the impact of COVID-19 on
suicidal tendencies in participants, 9.1% reported having more frequent thoughts of suicide since
the onset of the COVOD-19 pandemic. For both increased planning and attempting since the
start of the pandemic, 1.1% of participants responded affirmatively. Comparison to the preCOVID data is not possible due to a suspected errors in self reporting. All suicidal aspects
decreased, suicidal thought was 44.3%, suicidal planning was 18.2%, and suicide attempt was
10.2% (Table 18). This should not be possible, due to the same individuals being asked in the
initial and follow-up survey about their lifetime suicidal habits.
COVID-19 Impact and Perceived Stress
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These data have not yet been processed and will be analyzed in a follow up publication.
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Chapter 4: Conclusions
Pre-COVID Discussion
In this study, the prevalence of depressive symptoms in a diverse group of young adults
enrolled as undergraduate students was assessed, as well as associations between depression and
other psychiatric and substance use disorder phenotypes. ~26% of participants met criteria for
moderate to severe depression based on PHQ-9 score. This prevalence is much higher than the
general population, in which the 12-month prevalence is estimated at 6-10% (Hasin et al., 2018;
SAMHSA, 2019; Wang et al., 2017), but consistent with prior studies observing increased
depression prevalence in young adults (Eisenberg & Lipson, 2020; SAMHSA, 2019). The
Healthy Minds Study, an annual mental health survey of college students, found 36% of
participants to have at least moderate depression, as determined by PHQ-9, in the 2018-2019
school year (Eisenberg & Lipson, 2020). These data further support the higher rates of
depression observed in this cohort of collegiate young adults, compared to the general
population.
Participants in the present study also reported high rates of other psychiatric issues,
including anxiety, suicidality, and substance use. Higher PHQ-9 scores were correlated with
greater anxiety severity and higher rates of suicidality, including suicide ideation, planning, and
attempts. Students reporting more depressive symptoms were also more likely to be lifetime and
current cannabis users. These results are in line with prior research in college students (Furr et
al., 2001; Garlow et al., 2008; Hayatbakhsh et al., 2007; Tanaka-Matsumi & Kameoka, 1986).
Comorbidities associated with depression create risks to student safety, negatively affect overall
well-being, and represent additional obstacles to academic success (Davis et al., 2005; Eisenberg
et al., 2009; Greenberg et al., 2015; Turner et al., 2013). The presence of both depression and a

30
second psychiatric condition is associated with increases in symptom severity (Blanco et al.,
2012; IsHak et al., 2014; Joffe et al., 1993) and economic burden (Greenberg et al., 2015).
Students with both depression and anxiety also had lower average GPAs and higher dropout rates
than those with depression alone (Eisenberg et al., 2009).
PHQ-9 and AUDIT scores were positively correlated in this undergraduate cohort,
aligning with previous data supporting a significant association between alcohol use disorder and
depression (Boden & Fergusson, 2011). This study found PHQ-9 scores were correlated with
scores for the AUDIT-P, but not AUDIT-C, suggesting that depressive symptoms in this cohort
were not associated with increased alcohol consumption. Similar results were reported in a large
study of young adults, where poor mental health and depression were associated with drinkingrelated harms, but not with increased rates of frequent or heavy drinking (Weitzman, 2004). In
contrast, other studies of college students have found higher levels of alcohol use in individuals
reporting depressive symptoms (Doom & Haeffel, 2013; Keum et al., 2018). An analysis of
survey data from the National Longitudinal Study of Adolescent Health also found a higher
prevalence of depressive symptoms in young adults who were heavy drinkers, although no
difference in prevalence was observed between moderate drinkers and non-drinkers (Paschall et
al., 2005). The discrepancies in findings may be related to demographic differences between the
studies or the use of different questionnaires since the prior studies used varying instruments and
were not directly comparing scores from the PHQ-9 and AUDIT. In research in non-student
populations, there is some evidence that PHQ-9 scores may be correlated with scores on the full
AUDIT but not AUDIT-C (Dum et al., 2008; Hepner et al., 2009). Future studies will need to
focus on fully disentangling the associations between depression and alcohol consumption /
alcohol-related problems to better understand risks in young adults.
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Participants in this study reported positive lifetime and 12-month histories of cannabis
use of ~43% and 34%, respectively. These results are similar to a prior study of ~8,000
university students that described a 33% positive history of lifetime cannabis usage, which was
also determined by self-report (Kosviner et al., 1974). The increased incidence in this study is
likely due to substantial historical increases in cannabis usage among college students between
1975 and 2018 (Schulenberg et al., 2019). Additionally, these results are supported by two
studies estimating cannabis use among college students at ~30% (Johnston et al., 2007; MohlerKuo et al., 2003). In this cohort of collegiate young adults, ~17.5% had used cannabis within the
past year and had a CAST score indicative of severe cannabis use disorder and cannabis
dependence. A previous report described a 10.1% rate of cannabis dependence amongst first year
college students (Caldeira et al., 2008). The increased rate of cannabis dependence is possibly
due to differences in methods utilized to classify cannabis dependence and this study examining
collegiate young adults at any stage of their academic progression. Furthermore, the severity of
cannabis usage identified in this cohort is important because increased cannabis usage has
previously been shown to be associated with robust declines in GPA in college students
(Martinez et al., 2015). This study identified positive correlations between depression symptom
severity, lifetime cannabis usage, cannabis usage within the last year, and CAST scores.
Similarly, two previous studies of college students identified correlations between depression
symptom severity and alterations in cannabis usage (Beck et al., 2009; Moitra et al., 2016).
The overall validity of the data is supported by replication of several previously identified
associations between depression and other psychiatric phenotypes in college students.
Depression can have devastating consequences for young adults and comorbid psychiatric
conditions can further compound these problems. Comorbidities can make depression treatment
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less effective (Aina & Susman, 2006; Fava et al., 2008; Iosifescu et al., 2004) and may need to
be treated in parallel to see significant improvements (Brown et al., 1997; Coplan et al., 2015;
Koike et al., 2002; Nunes & Levin, 2004). Given these issues, understanding the correlates of
depression in young adults is essential for providing better guidance for school counseling
centers and treatment programs, and improving quality-of-life in this at-risk group. Once there is
more effective diagnostic and treatment tools available to this group, it will be possible to use
this psychiatric data to begin uncovering the biological and genetic marks of these diseases.
Mid-COVID Discussion
In the follow-up to the pre-COVID survey, psychiatric disorders were reassessed to
evaluate the impact of the COVID-19 pandemic in a portion of the initial college student cohort.
Depression scores, measured using the PHQ-9, appeared to remain consistent with 26% reporting
moderate to severe depression, which agrees with the current estimates for college students and a
higher prevalence than the general population (Beiter et al., 2015; Hasin et al., 2018; Ibrahim et
al., 2013; SAMHSA, 2019). Anxiety scores, measured using GAD-7, also remained consistent
with 52.3% reporting at least mild anxiety. This is also consistent with literature that anxiety
prevalence is higher in young adults and increasing in general (Beiter et al., 2015; Goodwin,
2015; Goodwin et al., 2020; Pedrelli et al., 2015). While the slight increases in both depression
and anxiety reported in this study were found to not be significant, several studies have reported
increased prevalence and severity of anxiety and depression due to COVID-19 in both the
general and young adult populations (Banerjee et al., 2021; Fruehwirth et al., 2021; Gloster et al.,
2020; Jia et al., 2021; Minihan et al., 2020; Oh et al., 2021; Vahratian et al., 2021). The small
sample size and survivor bias could be possible explanations to why the increase in this study
was not significant.
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The analysis of alcohol habits of students did yield significant findings. Approximately
90% of students reported alcohol consumption of some kind, with 15.9% reporting scores
indicative of harmful or hazardous drinking. While the alcohol consumption percentage agrees
with literature findings, the hazardous drinking percentage is lower than those reported in the
general population, 23%, and much lower than those reported in college students, 65% (Coulton,
2011; White & Hingson, 2013). This discrepancy could be due to the self-report nature of the
survey and the fact that WCU is a dry campus, thus leading students to be less inclined to report
heavy drinking habits. The pre to mid pandemic AUDIT numbers all increased, with a significant
increase in AUDIT-C and a trending significant increase in AUDIT-T. There was however no
significant increase in the AUDIT-P scores. These results suggest this cohort increased their
consumption of alcohol, without it becoming a problematic or hazardous. One study examining
alcohol use habits in college students after the onset of the pandemic discovered that college
students who moved home actually decreased their frequency and amount of alcohol
consumption, while students who reported remaining with peers were found to decrease their
average amount of alcohol but increase their frequency of days drinking per week (White et al.,
2020). Unfortunately, it is not possible for this cohort to be analyzed using these trends, because
housing questions were not included in the survey. However, it can be hypothesized that, based
on the trends, this cohort likely remained among peers due to the increase in frequency of
alcohol consumption. Other studies have found increased alcohol consumption in the general
population during the pandemic (Roberts et al., 2021; Vanderbruggen et al., 2020). Legal
drinking age was found to be a significant factor in the difference between under and over 21
year old AUDIT-T and AUDIT-P scores, but not AUDIT-C. This indicates age was a potential
confounding factor in the change in scores over COVID.
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Cannabis use in the cohort was above average, with ~49% reporting lifetime use and 21%
reporting scores indicative of severe cannabis use disorder and dependence. This is greater than
the estimated numbers found in other college students and is likely due to the historic increase of
cannabis use in college students (Kosviner et al., 1974; Mohler-Kuo et al., 2003). All CAST
categories of average score, lifetime use, and 12 month use, increased during the COVID-19
pandemic. However, only average CAST score trended towards significance, and a larger sample
size would be needed to assess the true nature of this trend. Other studies have noted marginal or
no significant increase in cannabis use during the pandemic (Brenneke et al., 2022;
Vanderbruggen et al., 2020).
Suicidal thought, planning, and attempt were asked in a self-harm section of the survey.
In total, 43% of the study participants reported suicidal thoughts, 15.9% indicated suicidal
planning, and 9% indicated an attempt in their lifetime. This is in line with studies that report
higher suicidal thoughts and attempts in high risk populations, including young adults (Dutheil et
al., 2019; Raue et al., 2014; Turner et al., 2013). However, it is higher than some reports of
suicidal thought, planning, and attempt prevalence in college students at around 22.3%, 6.1%,
and 3.2% respectively (Mortier et al., 2018). This disparity could be due to the vast variety of
assessment methods currently used in literature to assess suicidal tendencies (Harmer et al.,
2022). When looking at the impact of COVID-19, 9% of individuals reported increased thought
of suicide since the onset of the pandemic. However, the rest of the numbers indicated a decrease
in every suicidal category when compared to the pre-COVID data. These results must be
discounted, as this result should not be possible and indicates participants who initially indicated
lifetime suicidal thoughts, plans, or attempts then did not report the same result in the follow up
survey. This is understandable due to the serious and personal nature of these questions, as well
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as the stigma surrounding both mental health and suicide. This result calls to attention the need
for proper support to be in place for individuals suffering with self-harm tendencies, so that
misreporting such as this does not occur.
Limitations
Several limitations must be noted for these studies. The relatively small sample increases
the chances of false positives and provides insufficient power to analyze effects of sex and
race/ethnicity. Participants were also initially enrolled from a group of students who had
participated in a previous study, resulting in the cohort have higher proportions of women and
individuals of non-European ancestry than the wider student population. In the mid-COVID
survey, there was also a much higher proportion of white students than any of the other races,
which is not representative of the WCU student body. Although sex and race/ethnicity were
included as covariates in the statistical analysis, the sample demographics could conceivably
affect prevalence estimates if any of the phenotypes are associated with those factors (Eisenberg
et al., 2009). Also, psychiatric disorders often carry significant stigma and although the survey
participants were clearly instructed that all results would be de-identified, the self-reported
nature of the instruments has some potential for inaccuracy if any participants felt uncomfortable
reporting specific problems. This became apparent in this data during the mid-COVID survey
when analyzing the suicide questionnaire results. Individuals who previously reported thoughts,
plans, and attempts, retracted this in the follow up survey, resulting in lifetime numbers
decreased from the pre-COVID survey. This is no doubt due to the sensitive nature of these
questions and should be taken into consideration when studies such as these are conducted,
especially on high risk populations. In addition, the effects of COVID-19 cannot be
underestimated, and it is very possible survivor bias played a part in the individuals who were
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willing to participate in the follow up mid-COVID survey. This follow-up cohort may have
captured only the individuals who were least affected and willing to share their experience and it
is possible, due to the small sample size, these numbers could be underestimating the true
numbers. Finally, when individuals from the initial cohort were recontacted, many had graduated
and moved on from WCU. It is very possible the attempt to recontact never reached these
individuals due to out of date email information.
Future Research
Though the results in these studies provide useful insight into the nature of psychiatric
disorder prevalence in college age young adults and the impact COVID-19 has had on these
numbers, there is still much work to be done. This study will be furthered by adding additional
members and starting a new cohort to be genetically tested and phenotypically analyzed. Adding
a larger and more representative study population will counteract some of the limitations
discovered in this study. Also, there is still the COVID impact, PSS, and genetic results that will
be reported and analyzed in a follow up publication to this these that is in the working stages.
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Appendices
Appendix A: Tables
Table 1. Pre-COVID Cohort Demographic Information
Demographic Variable
Mean ± SD / Proportion
Age
20.47 ± 2.27
Gender
Male
21.65%
Female
78.35%
Race
White
63.92%
Black or African-American
22.68%
Asian
5.67%
Multi-racial
7.73%
Ethnicity
Hispanic
12.37%
Note: The cohort had an n of 194.
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Table 2. Pre-COVID Distribution of PHQ-9 Scores
PHQ-9 Total Score Depression Severity Individuals
0-4
None
84
5-9
Mild
60
10-14
Moderate
26
15-19
Moderate Severe
15
20-27
Severe
9

Proportion
43.30%
30.90%
13.40%
7.70%
4.60%
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Table 3. Pre-COVID Distribution of GAD-7 Scores
GAD-7 Total Score Anxiety Severity Individuals
0-4
None
84
5-9
Mild
54
10-14
Moderate
34
15-21
Severe
22

Proportion
43.30%
27.80%
17.50%
11.30%
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Table 4. Pre-COVID Correlation Coefficients for Depression and Other Psychiatric and Substance Use Disorder
Phenotypes.
PHQ- GAD- AUDI AUDI AUDI Cann- Cann- CAST Suicid Suicid Suicid
9
7
T
T-C
T-P
Lifeti 12mon
ee-Plan eme
th
Ideatio
Attem
n
pt
PHQ-9
1
GAD-7
.738** 1
*
AUDIT .183* .149* 1
AUDIT- .107
.027
.907** 1
C
*
AUDIT- .228** .255** .870** .582** 1
P
*
*
Cann.158* .104
.528** .511** .422** 1
Lifetime
*
*
*
Cann.199** .113
.517** .476** .443** .811** 1
12month
*
*
*
*
CAST
.281** .167* .563** .506** .496** .715** .886** 1
*
*
*
*
*
*
Suicide- .430** .310** -.095
-.101
-.066
.064
.084
.082
1
Ideation *
*
Suicide- .385** .245** -.006
-.009
-.001
.092
.118
.159* .584** 1
Plan
*
*
Suicide- .267** .122
.038
.017
.053
.019
.062
.141
.402** .674** 1
Attempt *
*
*
Note: * p ≤ 0.05 ** p < 0.01 *** p < 0.001
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Table 5. Mid-COVID Cohort Demographic Information
Demographic Variable
Mean ± SD / Proportion
Age
21.45 ± 1.61
Gender
Female
78.41%
Male
21.59%
Race
White
73.86%
Black or African-American
11.36%
Asian
6.82%
Multi-racial
7.95%
Ethnicity
Hispanic
7.95%
Note: The cohort had an n of 88.
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Table 6. Mid-COVID Distribution of PHQ-9 Scores
PHQ-9 Total Score Depression Severity Individuals
0-4
None
43
5-9
Mild
22
10-14
Moderate
14
15-19
Moderate Severe
7
20-27
Severe
2

Proportion
48.86%
25.00%
15.91%
7.95%
2.27%
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Table 7. PHQ-9 Pre and Mid-COVID Average Scores
Survey Period Mean ± SD
Pre-COVID
6.23 ± 5.97
Mid-COVID
6.33 ± 5.56
Note: t(87), p = 0.873
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Table 8. Mid-COVID Distribution of GAD-7 Scores
GAD-7 Total Score Anxiety Severity Individuals
0-4
None
42
5-9
Mild
23
10-14
Moderate
9
15-21
Severe
14

Proportion
47.7%
26.1%
10.2%
15.9%
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Table 9. GAD-7 Pre and Mid-COVID Average Scores
Survey Period Mean ± SD
Pre-COVID
6.57 ± 5.78
Mid-COVID
6.77 ± 5.73
Note: t(87), p = 0.644
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Table 10. Mid-COVID AUDIT Scores
AUDIT Section / Variable
Mean ± SD / Proportion
AUDIT-T
4.51 ± 3.77
AUDIT-C
3.25 ± 2.10
AUDIT-P
1.26 ± 2.40
Harmful or Hazardous Drinking
15.90%
Alcohol Dependence Males
0%
Alcohol Dependence Females
2.27%
Note: AUDIT-T represents total score. AUDIT-C represents consumption score.
AUDIT-P represents problematic drinking score.
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Table 11. Mid-COVID AUDIT Drinking Frequency Distribution
Frequency of Drinking
Participants Proportion
Never
9
10.23%
Monthly or Less
21
23.86%
Two to four times a month
35
39.77%
Two to three times a week
22
25.00%
Four or more times a week
1
1.14%
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Table 12. Mid-COVID AUDIT Drinking Amount Distribution
Number of Drinks Participants Proportion
1 or 2
45
51.14%
3 or 4
31
35.23%
5 or 6
12
13.64%
7 to 9
0
0.00%
10 or more
0
0.00%
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Table 13. AUDIT Pre and Mid-COVID Average Scores, Proportions, and Statistics
AUDIT Variable
Mean ± SD p-value
Pre-COVID AUDIT-T
3.53 ± 3.65
0.0822
Mid-COVID AUDIT-T
4.51 ± 3.77
Pre-COVID AUDIT-C
2.51 ± 2.29
0.0271
Mid-COVID AUDIT-C
3.25 ± 2.10
Pre-COVID AUDIT-P
1.02 ± 1.85
0.4607
Mid-COVID AUDIT-P
1.26 ± 2.40
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Table 14. Mid-COVID Under vs Over 21 Scores
AUDIT Variable
Mean ± SD p-value
Under 21 AUDIT-T
3.23 ± 3.26
0.0489
Over 21 AUDIT-T
4.94 ± 3.88
Under 21 AUDIT-C
2.64 ± 2.52
0.1739
Over 21 AUDIT-C
3.45 ± 1.94
Under 21 AUDIT-P
0.59 ± 0.96
0.0242
Over 21 AUDIT-P
1.48 ± 2.70
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Table 15. Mid-COVID Distribution of CAST Scores and Reported Cannibals Use
CAST Variable
Mean ± SD / Proportion
Lifetime Use
48.86%
12 Month Use
38.64%
Severe Cannabis Use Disorder and Dependence
21.59%
CAST Lifetime Scores
3.70 ± 5.30
CAST 12 Month Scores
9.59 ± 4.04
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Table 16. CAST Pre and Mid-COVID Average Scores and Use
CAST Score, Use, and Period Mean ± SD / Proportion
Pre-COVID CAST
2.91 ± 4.89
Mid-COVID CAST
3.70 ± 5.30
Pre-COVID Lifetime Use
39.77%
Mid-COVID Lifetime Use
48.86%
Pre-COVID 12 Month Use
30.68%
Mid-COVID 12 Month Use
38.63%
Note: For Pre-COVID CAST and Mid-COVID CAST t(87), p = 0.064
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Table 17. Mid-COVID Suicidality Distribution
Suicide Variable
Participants
Thought
38
Increase in Thought since COVID
8
Plan
14
Increase in Plan since COVID
1
Attempt
8
Attempt since COVID
1

Proportion
43.18%
9.09%
15.91%
1.14%
9.09%
1.14%
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Table 18: Suicidality Pre and Mid-COVID Proportions
Suicide Variable and Period Proportion
Pre-COVID Thought
44.31%
COVID Thought
43.18%
Initial Plan
18.18%
COVID Plan
15.91%
Initial Attempt
10.22%
COVID Attempt
9.09%
Note: This data represents an error in self reporting and was not analyzed further.
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Appendix B: Citi Training

COLLABORATIVE INSTITUTIONAL TRAINING INITIATIVE (CITI PROGRAM)
COMPLETION REPORT - PART 1 OF 2
COURSEWORK REQUIREMENTS*
* NOTE: Scores on this Requirements Report reflect quiz completions at the time all requirements for the course were met. See list below for details.
See separate Transcript Report for more recent quiz scores, including those on optional (supplemental) course elements.
•
•
•
•

Name:
Institution Affiliation:
Institution Email:
Institution Unit:

Madison James (ID: 8783203)
West Chester University of Pennsylvania (ID: 3022)
MJ896931@wcupa.edu
Honors

•
•
•
•

Curriculum Group:
Course Learner Group:
Stage:
Description:

Biomedical Research - Basic/Refresher
Same as Curriculum Group
Stage 1 - Basic Course
Choose this group to satisfy CITI training requirements for Investigators and staff involved primarily in biomedical
research with human subjects.

•
•
•
•
•

Record ID:
Completion Date:
Expiration Date:
Minimum Passing:
Reported Score*:

38102791
28-Aug-2020
28-Aug-2023
80
95

REQUIRED AND ELECTIVE MODULES ONLY

DATE
COMPLETED

SCORE

Belmont Report and Its Principles (ID: 1127)

16-Jan-2020

3/3
(100%)
5/5
(100%)
5/5
(100%)
5/5
(100%)
5/5
(100%)
3/4 (75%)
3/3
(100%)
4/5 (80%)
3/3
(100%)
5/5
(100%)
5/5
(100%)
4/4
(100%)
4/5 (80%)
3/3
(100%)

Recognizing and Reporting Unanticipated Problems Involving Risks to Subjects or Others in Biomedical Research 28-Aug-2020
(ID: 14777)
Basic Institutional Review Board (IRB) Regulations and Review Process (ID: 2)
28-Aug-2020
Informed Consent (ID: 3)

28-Aug-2020

History and Ethics of Human Subjects Research (ID: 498)

28-Aug-2020

Social and Behavioral Research (SBR) for Biomedical Researchers (ID: 4)
Records-Based Research (ID: 5)

28-Aug-2020
28-Aug-2020

Genetic Research in Human Populations (ID: 6)
Research Involving Children (ID: 9)

28-Aug-2020
28-Aug-2020

FDA-Regulated Research (ID: 12)

28-Aug-2020

Research and HIPAA Privacy Protections (ID: 14)

28-Aug-2020

Vulnerable Subjects - Research Involving Workers/Employees (ID: 483)

28-Aug-2020

Conflicts of Interest in Human Subjects Research (ID: 17464)
Avoiding Group Harms - U.S. Research Perspectives (ID: 14080)

21-Jan-2020
28-Aug-2020

For this Report to be valid, the learner identified above must have had a valid affiliation with the CITI Program subscribing institution
identified above or have been a paid Independent Learner.
Verify at: www.citiprogram.org/verify/?k619c7455-bb2f-4d0f-92a2-cc34fffd5e96-38102791
Collaborative Institutional Training Initiative (CITI Program)
Email: support@citiprogram.org
Phone: 888-529-5929
Web: https://www.citiprogram.org
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Appendix C: Approved IRB

Office of Research and Sponsored Programs
West Chester University | Wayne Hall
West Chester, PA 19383
610-436-3557 www.wcupa.edu
INSTITUTIONAL REVIEW BOARD APPLICATION PACKAGE

REVISED COMMON RULE
Effective 1/21/2019
The application package should be one Microsoft Word document assembled in the following order:
1.
2.
3.
4.
5.
6.
7.
8.
9.

Section I: Project Information – Fill in all appropriate information and check all appropriate boxes under review categories.
Section II: Detailed Protocol – Concise, complete responses following each individually lettered request for information.
Include all information requested.
Completed Checklist
Section III: Signatures (accepted forms of signature include: scans of original signatures, electronic signatures, and typed
signatures)
Appropriate Informed Consent Form(s).
Any research instrument used (questionnaire, survey, psychological test, etc.).
Letters of approval from participating institutions, if any. (must be on institution letter head with signature)
External support proposal, if any (one only, attached to the application with original signatures). Do not include the budget.
CITI human subject training completion certificate. Please visit http://www.wcupa.edu/research/irb.aspx for more
information.

Submission Instructions: Visit http://wcupa.edu/research/irb.aspx for more information.
1. Please e-mail complete application and all attachments as one Microsoft Word document to irb@wcupa.edu. A submission
containing multiple files will not be accepted. The IRB cannot edit or add to your application once submitted. It is
suggested you keep a complete editable copy, preferably electronic, in case revisions are necessary.
2.

Once your application passes initial vetting (2-4 business days), you will receive an e-mail stating that your application has
been forwarded to a committee member for review. You will then be provided contact information for your reviewer and
an estimated time for approval.

3.

Any questions or concerns regarding your review can be sent directly to your reviewer.

* All PI’s, co-PI’s, and faculty sponsors submitting a protocol to the IRB are required to provide evidence of CITI human subject
training. Please Visit: http://www.wcupa.edu/research/irb.aspx for more information.
Training must have been completed no more than 3 years from date of this application.
Please note:
➢ If you have any additions or changes in procedures involving human subjects, it is required to revise your IRB application
with the amendments and submit to the IRB as a revision (i.e., under I.G. check off that the submission is a revision). Please
note that your revised application will go through IRB office’s routine application processing. You cannot employ the
revisions until you receive IRB approval of your revised application submission.
➢

Any and all adverse effects to the human subjects are required to be brought to the attention of the IRB immediately and in
writing.

➢

All IRB protocols as Full Board Review and some expedited will be required to undergo a continuing review process at an
interval that is no more than one year from the protocol approval date.

Any questions regarding this form can be directed to the Office of Research and Sponsored Programs at irb@wcupa.edu or 610-4363557
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